Department of Endocrinology and Diabetology, The Children's Memorial Health Institute (CMHI), Al. Dzieci Polskich 20, 04-730, Warsaw, Poland.
The Medicine and Health Sciences Faculty, University of Jan Kochanowski, Al. IX Wieków Kielc 19A, 25-317, Kielce, Poland.
Endocrine. 2019 Nov;66(2):125-136. doi: 10.1007/s12020-019-02036-2. Epub 2019 Nov 7.
Cushing's disease (CD) is a rare endocrine condition caused by a corticotroph pituitary tumor that produces adrenocorticotropic hormone. The current state of knowledge of CD treatment is presented in this article including factors that can be helpful in predicting remission and/or recurrence of the disease. The primary goals in CD treatment are quick diagnosis and effective, prompt treatment as the persistent disease is associated with increased morbidity and mortality. Cooperation of a team consisting of experienced pediatrician/adult endocrinologist, neuroradiologist, transsphenoidal neurosurgeon and (if necessary) radiotherapist contribute to the best treatment effects.
库欣病(CD)是一种罕见的内分泌疾病,由产生促肾上腺皮质激素的垂体促皮质细胞瘤引起。本文介绍了 CD 的治疗现状,包括有助于预测疾病缓解和/或复发的因素。CD 治疗的主要目标是快速诊断和有效、及时的治疗,因为持续的疾病与更高的发病率和死亡率相关。由经验丰富的儿科医生/成人内分泌学家、神经放射学家、经蝶窦神经外科医生和(如有必要)放射治疗师组成的团队合作有助于获得最佳的治疗效果。